Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders

View source ↗

Summary

This clinical trial investigates monitoring of circulating B-cells, rituximab levels, and anti-drug antibodies in patients with autoimmune cytopenia, connective…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Autoimmune Cytopenia, Connective Tissue Disorder | Status: RECRUITING